Treatment of colorectal cancer with a simultaneous application of 5-fluorouracil (5-FU)/sodium folinic acid: Results of a large observation study

被引：0
|
作者：
Hofheinz, R. D. [1 ]
Hutschenreuther, U. [1 ]
Sauer, U. [1 ]
Eschenburg, H. [1 ]
Rudolph, R. [1 ]
Tummes, D. [1 ]
Weinberg, R. [1 ]
Guggenberger, D. [1 ]
机构：
[1] Onkol Zentrum, Mannheim, Germany
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：I44 / I44
页数：1
相关论文
共 50 条
  • [1] Treatment of colorectal cancer and other turnours with a simulataneous application of 5-fluorouracil (5-FU)/sodium folinate (ONCOFOLIC®):: Results of a large observation study
    Hofheinz, R. -D.
    Hutschenreuther, U.
    Sauer, U.
    Eschenburg, H.
    Rudolph, R.
    Tummes, D.
    Weinberg, R.
    Guggenberger, D.
    ONKOLOGIE, 2008, 31 : 88 - 88
  • [2] TREATMENT OF ADVANCED MALIGNANCY WITH 5-FLUOROURACIL (5-FU) COMBINED WITH FOLINIC ACID (FA)
    LOPEZ, AR
    VANTILBURG, A
    BRADLEY, T
    JENSEN, B
    ZIEGLER, J
    ENGELBERG, C
    DEISSEROTH, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 178 - 178
  • [3] FOLINIC ACID (FA) AND 5-FLUOROURACIL (5-FU) - PHASE-I-II STUDY
    CUNNINGHAM, JR
    BUKOWSKI, RM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 221 - 221
  • [4] 5-fluorouracil (5-FU),folinic acid (FA) and oxaliplatin (FUFOX) as second chemotherapy in patients with metastatic colorectal cancer (MCRC)
    Andric, Z.
    Murtezani, Z.
    Kovcin, V
    Gutovic, J.
    Kostic, S.
    ANNALS OF ONCOLOGY, 2006, 17 : 66 - 67
  • [5] HIGH-DOSE 5-FLUOROURACIL (5-FU) AND FOLINIC ACID IN ADVANCED COLORECTAL SITES OF DISEASE CANCER RESISTANT TO STANDARD-DOSE LOCAL 5-FU TREATMENT - RESULTS OF A LIVER PHASE-II STUDY
    JAGER, E
    KLEIN, O
    WACHTER, B
    MULLER, B
    BRAUN, U
    KNUTH, A
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (10) : 1717 - 1717
  • [6] Phase-II-study of a 24-h infusion with 5-fluorouracil (5-FU) and simultaneous sodium-folinic acid in the first-line-treatment of advanced colorectal cancer: Interim analysis
    Hofheinz, R
    Hartung, G
    Wein, A
    Riedel, C
    Kuhfahl, J
    Rost, A
    Brecht, A
    Bolte, R
    Fritze, D
    Keilholz, U
    Kreuser, ED
    Queisser, W
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S81 - S81
  • [7] FOLINIC ACID + 5-FLUOROURACIL (5-FU) VERSUS EQUIDOSE 5-FU IN ADVANCED COLORECTAL-CANCER - PHASE-III STUDY OF GISCAD (ITALIAN-GROUP-FOR-THE-STUDY-OF-DIGESTIVE-TRACT-CANCER)
    LABIANCA, R
    PANCERA, G
    AITINI, E
    BARNI, S
    BERETTA, A
    BERETTA, GD
    CESANA, B
    COMELLA, G
    COZZAGLIO, L
    CRISTONI, M
    SPAGNOLLI, P
    FRONTINI, L
    GOTTARDI, O
    MARTIGNONI, G
    SCAPATICCI, R
    SMERIERI, F
    VINCI, M
    ZADRO, A
    ZANIBONI, A
    LUPORINI, G
    ANNALS OF ONCOLOGY, 1991, 2 (09) : 673 - 679
  • [8] Cardiotoxicity in 5-fluorouracil folinic acid treatment for metastatic colorectal cancer
    Käfer, G
    Achtnich, M
    Willer, A
    Weiss, A
    Queisser, W
    ONKOLOGIE, 1998, 21 (04): : 324 - 327
  • [9] Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC)
    Peeters, M.
    Raoul, J.-L.
    Van Laethem, J.-L.
    Rougier, P.
    Brezault, C.
    Husseini, F.
    Cals, L.
    Zubel, A.
    Vedovato, J.-C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 188 - 188
  • [10] Phase III study of bolus 5-fluorouracil (5-FU)/folinic acid vs high dose 24h 5-FU infusion/folinic acid (FA) plus oxaliplatin(OXA) in metastatic colorectal cancer (MCRC).
    Hospers, G
    Schaapveld, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 254S - 254S
12345